Cytokinetics has disclosed the pricing of the public offering of its common stock.

SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritten public offering of 9,803,922 shares of its…

Read More: https://www.globenewswire.com/news-release/2024/05/23/2886964/35409/en/Cytokinetics-Announces-Pricing-of-Public-Offering-of-Common-Stock.html